Literature DB >> 21859996

Prostate cancer: evolution or revolution?

Eric J Small1, Johann Sebastian de Bono.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21859996     DOI： 10.1200/JCO.2011.37.8653

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Prognostic potential of ERG (ETS-related gene) expression in prostatic adenocarcinoma.

Authors:  A Marcell Szász; Attila Majoros; Philip Rosen; Shiv Srivastava; Albert Dobi; Attila Szendrői; Janina Kulka; Péter Nyirády
Journal:  Int Urol Nephrol       Date:  2013-05-18       Impact factor: 2.370

2.  The tumor microenvironment in prostate cancer: elucidating molecular pathways for therapy development.

Authors:  Paul G Corn
Journal:  Cancer Manag Res       Date:  2012-07-25       Impact factor: 3.989

3.  Sequencing of cabazitaxel in metastatic castrate-resistant prostate cancer: a case report.

Authors:  Donald Colbourn
Journal:  Case Rep Oncol       Date:  2012-06-21

4.  Dendritic cell-specific delivery of Flt3L by coronavirus vectors secures induction of therapeutic antitumor immunity.

Authors:  Christian Perez-Shibayama; Cristina Gil-Cruz; Monika Nussbacher; Eva Allgäuer; Luisa Cervantes-Barragan; Roland Züst; Burkhard Ludewig
Journal:  PLoS One       Date:  2013-11-28       Impact factor: 3.240

5.  Should active surveillance in prostate cancer patients be based on a single histological assessment?

Authors:  Lukasz Nyk; Tomasz Golabek; Jakub Dobruch; Michał Andrzej Skrzypczyk; Tomasz Dzik; Maciej Wysocki; Piotr L Chłosta; Andrzej Borówka
Journal:  Cent European J Urol       Date:  2014-08-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.